07:29 AM EDT, 05/29/2025 (MT Newswires) -- Roivant Sciences ( ROIV ) reported a fiscal Q4 net loss Thursday of $0.29 per share, wider than a loss of $0.19 a year earlier.
Analysts surveyed by FactSet expected a loss of $0.31 per share.
Revenue for the three months ended March 31 was $7.6 million, down from $9 million a year ago.
Analysts surveyed by FactSet expected $54.1 million.